Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gianluca Trifirò

Showing results (1-10 of 283) with videos related to

Pageof 29
Sort By:
Current Infectious Disease Reports|March 12, 2011
Antipsychotic drug use and community-acquired pneumoniaGianluca Trifirò
Recenti Progressi in Medicina|December 7, 2019
Gianluca Trifirò
Recenti Progressi in Medicina|July 19, 2022
[The role of real-world evidence for the study of rare diseases epidemiology and the post-marketing evaluation of orphan drugs.]Salvatore Crisafulli, Gianluca Trifirò
Current Drug Metabolism|April 19, 2011
Age-related changes in pharmacodynamics: focus on drugs acting on central nervous and cardiovascular systemsGianluca Trifirò, Edoardo Spina
Thorax|September 15, 2023
Is antidepressant use a concern for patients with COPD?Gianluca Trifirò, Salvatore Crisafulli
Expert Review of Clinical Pharmacology|March 17, 2020
The potential role of big data in the detection of adverse drug reactionsJanet Sultana, Gianluca Trifirò
Expert Opinion on Drug Safety|November 29, 2014
Antipsychotic use in elderly patients and the risk of pneumoniaGiovanni Gambassi, Janet Sultana, Gianluca Trifirò
BMJ (Clinical Research Ed.)|February 26, 2026
Transparency of post-authorisation studiesJanet Sultana, Salvatore Crisafulli, Gianluca Trifirò
Expert Opinion on Biological Therapy|December 1, 2017
Interchangeability of biosimilar and biological reference product: updated regulatory positions and pre- and post-marketing evidenceGianluca Trifirò, Ilaria Marcianò, Ylenia Ingrasciotta
Pharmacological Research|November 4, 2008
Use of antipsychotics in elderly patients with dementia: do atypical and conventional agents have a similar safety profile?Gianluca Trifirò, Edoardo Spina, Giovanni Gambassi
Pageof 29

Showing results (1-10 of 283) with videos related to

Sort By:
Pageof 29
Current Infectious Disease Reports|March 12, 2011
Antipsychotic drug use and community-acquired pneumoniaGianluca Trifirò
Recenti Progressi in Medicina|December 7, 2019
Gianluca Trifirò
Recenti Progressi in Medicina|July 19, 2022
[The role of real-world evidence for the study of rare diseases epidemiology and the post-marketing evaluation of orphan drugs.]Salvatore Crisafulli, Gianluca Trifirò
Current Drug Metabolism|April 19, 2011
Age-related changes in pharmacodynamics: focus on drugs acting on central nervous and cardiovascular systemsGianluca Trifirò, Edoardo Spina
Thorax|September 15, 2023
Is antidepressant use a concern for patients with COPD?Gianluca Trifirò, Salvatore Crisafulli
Expert Review of Clinical Pharmacology|March 17, 2020
The potential role of big data in the detection of adverse drug reactionsJanet Sultana, Gianluca Trifirò
Expert Opinion on Drug Safety|November 29, 2014
Antipsychotic use in elderly patients and the risk of pneumoniaGiovanni Gambassi, Janet Sultana, Gianluca Trifirò
BMJ (Clinical Research Ed.)|February 26, 2026
Transparency of post-authorisation studiesJanet Sultana, Salvatore Crisafulli, Gianluca Trifirò
Expert Opinion on Biological Therapy|December 1, 2017
Interchangeability of biosimilar and biological reference product: updated regulatory positions and pre- and post-marketing evidenceGianluca Trifirò, Ilaria Marcianò, Ylenia Ingrasciotta
Pharmacological Research|November 4, 2008
Use of antipsychotics in elderly patients with dementia: do atypical and conventional agents have a similar safety profile?Gianluca Trifirò, Edoardo Spina, Giovanni Gambassi
Pageof 29